Background
PDAC, pancreatic ductal adenocarcinoma
PANCREATIC DUCTAL ADENOCARCINOMA, LIVER METASTASIS
Nearly one fourth of patients with pancreatic ductal adenocarcinoma (PDAC) occur to liver metastasis after surgery, and liver metastasis is a risk factor for prognosis for those patients with surgery therapy. However, there is no effective way to predict liver metastasis post-operation.
